Credit: Adobe Stock/eddows Clinical, endoscopic, and laboratory assessments revealed the infliximab biosimilar CT-P13 was comparable to the reference drug in terms of safety and efficacy among...
Yanjie Hao, PhD Credit: Asia Pacific Lupus Collaboration A treat-to-target (T2T) strategy was shown to significantly improve both clinical outcomes and health-related quality of life (HRQoL)...
A matching-adjusted indirect comparison of eGFR slopes from the PROTECT trial, the NefIgArd trial, and the RaDaR registry is offering new insight into the effects of...